These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 16006881

  • 1. Use of extended pattern technique for initial prostate biopsy.
    Siu W, Dunn RL, Shah RB, Wei JT.
    J Urol; 2005 Aug; 174(2):505-9. PubMed ID: 16006881
    [Abstract] [Full Text] [Related]

  • 2. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS.
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [Abstract] [Full Text] [Related]

  • 3. The independent impact of extended pattern biopsy on prostate cancer stage migration.
    Master VA, Chi T, Simko JP, Weinberg V, Carroll PR.
    J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288
    [Abstract] [Full Text] [Related]

  • 4. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?
    Chan TY, Chan DY, Stutzman KL, Epstein JI.
    J Urol; 2001 Dec; 166(6):2181-4. PubMed ID: 11696731
    [Abstract] [Full Text] [Related]

  • 5. Increased detection of clinically significant prostate cancer by additional sampling from the anterior lateral horns of the peripheral zone in combination with the standard sextant biopsy.
    Miyake H, Sakai I, Harada K, Hara I, Eto H.
    Int J Urol; 2004 Jun; 11(6):402-6. PubMed ID: 15157210
    [Abstract] [Full Text] [Related]

  • 6. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
    Campos-Fernandes JL, Bastien L, Nicolaiew N, Robert G, Terry S, Vacherot F, Salomon L, Allory Y, Vordos D, Hoznek A, Yiou R, Patard JJ, Abbou CC, de la Taille A.
    Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
    [Abstract] [Full Text] [Related]

  • 7. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.
    Ochiai A, Troncoso P, Chen ME, Lloreta J, Babaian RJ.
    J Urol; 2005 Dec; 174(6):2164-8, discussion 2168. PubMed ID: 16280756
    [Abstract] [Full Text] [Related]

  • 8. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR, McNeal JE, Gill H, Presti JC.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):386-91. PubMed ID: 15145152
    [Abstract] [Full Text] [Related]

  • 9. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR, Zippe CD, Abouassaly R, Schoenfield L, Magi-Galluzzi C, Jones JS.
    J Urol; 2008 May 01; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [Abstract] [Full Text] [Related]

  • 10. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F.
    Urology; 2009 May 01; 73(5):1087-91. PubMed ID: 19195695
    [Abstract] [Full Text] [Related]

  • 11. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
    Miyake H, Sakai I, Harada K, Hara I, Eto H.
    Int J Urol; 2005 Mar 01; 12(3):270-4. PubMed ID: 15828954
    [Abstract] [Full Text] [Related]

  • 12. Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies.
    Kassouf W, Nakanishi H, Ochiai A, Babaian KN, Troncoso P, Babaian RJ.
    J Urol; 2007 Jul 01; 178(1):111-4. PubMed ID: 17499289
    [Abstract] [Full Text] [Related]

  • 13. Prostate biopsy: who, how and when. An update.
    Djavan B, Milani S, Remzi M.
    Can J Urol; 2005 Feb 01; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [Abstract] [Full Text] [Related]

  • 14. Combined prostate-specific antigen density and biopsy features to predict "clinically insignificant" prostate cancer.
    Loeb S, Roehl KA, Thaxton CS, Catalona WJ.
    Urology; 2008 Jul 01; 72(1):143-7. PubMed ID: 18436287
    [Abstract] [Full Text] [Related]

  • 15. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis.
    Cupp MR, Bostwick DG, Myers RP, Oesterling JE.
    J Urol; 1995 May 01; 153(5):1543-8. PubMed ID: 7714976
    [Abstract] [Full Text] [Related]

  • 16. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS, Swords K, Schultz H, Carson CC, Wallen EM.
    J Urol; 2009 Feb 01; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [Abstract] [Full Text] [Related]

  • 17. Prostate specific antigen density correlates with features of prostate cancer aggressiveness.
    Kundu SD, Roehl KA, Yu X, Antenor JA, Suarez BK, Catalona WJ.
    J Urol; 2007 Feb 01; 177(2):505-9. PubMed ID: 17222621
    [Abstract] [Full Text] [Related]

  • 18. Extended pattern prostate biopsy does not minimize the volume-grade bias in prostate cancer detection.
    Al-Ghamdi AM, Lockwood G, Toi A, Kulkarni GS, Evans A, Finelli A, Zlotta AR, Fleshner N.
    J Urol; 2008 Apr 01; 179(4):1332-4. PubMed ID: 18289588
    [Abstract] [Full Text] [Related]

  • 19. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT, Eroglu A, Sahin A, Zorlu F, Ozen H.
    Urol Oncol; 2007 Apr 01; 25(5):376-82. PubMed ID: 17826653
    [Abstract] [Full Text] [Related]

  • 20. Significance of minute focus of adenocarcinoma on prostate needle biopsy.
    Samaratunga H, Yaxley J, Kerr K, McClymont K, Duffy D.
    Urology; 2007 Aug 01; 70(2):299-302. PubMed ID: 17826493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.